Rifampicin was reported to inhibit amyloid-Î² oligomerization and tau hyperphosphorylation in mouse models and could serve as a promising available medicine for the prevention of Alzheimer disease (AD). To examine whether rifampicin has such preventive effects in humans, we retrospectively reviewed (18)F-FDG-PET findings of elderly patients with mycobacterium infection treated with rifampicin.